Tara Laurine Roberts
Overview
Explore the profile of Tara Laurine Roberts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chan W, Chua W, Wilkinson K, Epitakaduwa C, Mandaliya H, Descallar J, et al.
Int J Mol Sci
. 2024 Aug;
25(16).
PMID: 39201360
Caudal type homeobox transcription factor 2 (CDX2) is a gastrointestinal cancer biomarker that regulates epithelial development and differentiation. Absence or low levels of CDX2 have been associated with poor prognosis...
2.
Habashy P, Lea V, Wilkinson K, Wang B, Wu X, Roberts T, et al.
Int J Mol Sci
. 2023 Dec;
24(24).
PMID: 38139338
and mutation rates in colorectal cancer (CRC) reported from various mono-ethnic studies vary amongst different ethnic groups. However, these differences in mutation rates may not be statistically significant or may...
3.
Yang E, Chua W, Ng W, Roberts T
Biomedicines
. 2021 Dec;
9(12).
PMID: 34944729
Although strong connections exist between the carcinogenesis of gastric cancer and chronic inflammation, gastric cancer is unique in that the chronic gastritis which frequently precedes carcinogenesis is strongly associated with...
4.
Wilkinson K, Ng W, Roberts T, Becker T, Lim S, Chua W, et al.
J Clin Pathol
. 2021 Mar;
74(10):625-634.
PMID: 33753562
The role of the local tumour and stromal immune landscape is increasingly recognised to be important in cancer development, progression and response to therapy. The composition, function, spatial orientation and...
5.
Venigalla M, Roberts T, Raju R, Mrad M, Bodkin F, Kopp K, et al.
Fitoterapia
. 2021 Feb;
150:104843.
PMID: 33539940
In contrast to ancient Western and Asian cultures, medicinal plants of the Aboriginal and Torres Strait Islanders in Australia have not been as intensively studied for their molecular composition and...
6.
Aghajani M, Cooper A, McGuire H, Jeffries T, Saab J, Ismail K, et al.
Cancer Immunol Immunother
. 2019 Oct;
68(12):1921-1934.
PMID: 31637475
Blockade of the PD-1/PD-L1 pathway with targeted monoclonal antibodies has demonstrated encouraging anti-tumour activity in multiple cancer types. We present the case of a patient with BRAF-negative stage IVC anaplastic...
7.
Aghajani M, Roberts T, Yang T, McCafferty C, Caixeiro N, DeSouza P, et al.
Endocr Connect
. 2019 Jun;
8(7):1040-1051.
PMID: 31252406
To date, no research evaluating the predictive capabilities of soluble programmed cell death-ligand 1 (sPD-L1) in thyroid cancer patients has been performed. We aimed to investigate the prognostic significance of...
8.
Razdan A, de Souza P, Roberts T
Curr Cancer Drug Targets
. 2018 Apr;
18(10):929-944.
PMID: 29644941
Prostate cancer (PCa) is the most common non-skin cancer in men worldwide, resulting in significant mortality and morbidity. Depending on the grade and stage of the cancer, patients may be...
9.
Nikesitch N, Lee J, Ling S, Roberts T
Clin Transl Immunology
. 2018 Feb;
7(1):e1007.
PMID: 29484184
Multiple myeloma (MM) is a haematological malignancy of mature antibody-secreting plasma cells. Currently, MM is incurable, but advances in drug treatments have increased patient lifespan. One of the characteristics of...
10.
Weng Ng W, Shin J, Roberts T, Wang B, Lee C
J Clin Pathol
. 2016 Mar;
69(7):557-62.
PMID: 26941182
Polo-like kinase 1 (PLK1) is an essential protein in communicating cell-cycle progression and DNA damage. Overexpression of PLK1 has been validated as a marker for poor prognosis in many cancers....